Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...

While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on the lookout for...plus one common myth about polyps.

Many patients attribute these symptoms to frequent “colds”. They may be prescribed antibiotics and other symptomatic ...

AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

A new study reveals that popular low-carb, low-fiber diets may significantly increase the risk of colorectal cancer, ...

Cambridge: AstraZeneca and Amgen's Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for ...

Nasir Rajpoot, CEO and CSO of Histofy, reveals AI-powered screening and the triaging processes for large bowel endoscopic ...

AstraZeneca and Amgen secure CHMP support for Tezspire in nasal polyps and Koselugo in neurofibromatosis after strong Phase 3 ...

AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.

“Screening allows us to detect cancer early. Colorectal cancer often begins with small growths in the intestine called polyps. Each polyp has a 30 to 40 percent chance of developing into cancer. If we ...

In recent years, studies have taken a closer look at whether certain lifestyle choices might up your risk for colon cancer.